Inventor
POLLARD MATTHEW
AU23 patents
⚠️ This page may combine multiple inventors who share the name “POLLARD MATTHEW”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
TEVA PHARMACEUTICALS AUSTRALIA PTY LTD
9 patentsUS10822422B2Nov 3, 2020
Antibodies against TL1a and uses thereof
TEVA PHARMACEUTICALS AUSTRALIA PTY LTD10 citations81
US9611322B2Apr 4, 2017
Fusions of antibodies to CD38 and attenuated interferon alpha
TEVA PHARMACEUTICALS AUSTRALIA PTY LTD6 citations81
US10544199B2Jan 28, 2020
Interferon alpha 2B variants
TEVA PHARMACEUTICALS AUSTRALIA PTY LTD7 citations79
US10981986B2Apr 20, 2021
Fusions of antibodies to CD38 and attenuated interferon alpha
TEVA PHARMACEUTICALS AUSTRALIA PTY LTD2 citations70
US9963515B2May 8, 2018
Anti-CD38 antibodies and fusions to attenuated interferon alpha-2B
TEVA PHARMACEUTICALS AUSTRALIA PTY LTD5 citations70
US11319356B2May 3, 2022
Interferon alpha 2B variants
TEVA PHARMACEUTICALS AUSTRALIA PTY LTD2 citations68
US11117975B2Sep 14, 2021
Anti-CD38 antibodies and fusions to attenuated interferon alpha-2B
TEVA PHARMACEUTICALS AUSTRALIA PTY LTD1 citations60
US12410256B2Sep 9, 2025
Antibodies that specifically bind to TL1a and methods of treating gastrointestinal or lung diseases
TEVA PHARMACEUTICALS AUSTRALIA PTY LTD0 citations59
US8901279B2Dec 2, 2014
Humanized antibodies with anti-tumor activity
TEVA PHARMACEUTICALS AUSTRALIA PTY LTD0 citations47
CEPHALON LLC
5 patentsUS11725052B2Aug 15, 2023
Anti-PAR-2 antibodies and methods of use thereof
CEPHALON LLC2 citations65
US12410247B2Sep 9, 2025
Polynucleotides encoding antibodies that specifically bind to human IL-15
CEPHALON LLC0 citations59
US12162946B2Dec 10, 2024
Antibodies that specifically bind to TL1A and methods of treating gastrointestinal disease
CEPHALON LLC0 citations59
US12018084B2Jun 25, 2024
Anti-CXCR2 antibodies and uses thereof
CEPHALON LLC0 citations56
US12384841B2Aug 12, 2025
Anti-PAR-2 antibodies and methods of use thereof
CEPHALON LLC0 citations55
CEPHALON INC
4 patentsUS10138296B2Nov 27, 2018
Antibodies that specifically bind to TL1A
CEPHALON INC17 citations91
US11220549B2Jan 11, 2022
Antibodies that specifically bind to TL1A and methods of treating respiratory tract diseases
CEPHALON INC8 citations82
US11267883B2Mar 8, 2022
Antibodies that specifically bind to human IL-15 and uses thereof
CEPHALON INC5 citations81
US11332534B2May 17, 2022
Anti-CXCR2 antibodies and uses thereof
CEPHALON INC1 citations57